U.S. Approves First drug for Psychosis Linked to Parkinson

Share

(May 2, 2016) - Nuplazid, Acadia Pharmaceuticals’ drug for psychosis linked to Parkinson's disease was approved in the United States on Friday, becoming the first treatment for the condition to get a nod in the country. Read more…

Click for a printer friendly version

Back to top